# Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity

> **NCT07241338** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Jing Liu** · enrollment: 104 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** sacubitril/allisartan
- **DRUG:** Amlodipine

## Key facts

- **NCT ID:** NCT07241338
- **Lead sponsor:** Jing Liu
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-11
- **Primary completion:** 2026-11
- **Final completion:** 2027-06
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07241338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07241338, "Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT07241338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*